PRESS RELEASE published on 02/01/2023 at 09:45, 2 years 10 months ago Amundi Asset Management: Amundi will proceed to mergers operations on February 10th, 2023
PRESS RELEASE published on 01/19/2023 at 13:05, 2 years 10 months ago Amundi Asset Management: AMUNDI ETF - Important Information - Name Changes
PRESS RELEASE published on 01/18/2023 at 10:15, 2 years 10 months ago AMUNDI ETF – Important Information - Index & Name Change - AMUNDI INDEX MSCI JAPAN - UCITS ETF DR - LU1602144815
PRESS RELEASE published on 01/16/2023 at 12:00, 2 years 10 months ago Amundi Asset Management: AMUNDI ETF - Important Information - Index & Name Change - Lyxor ESG Euro Corporate Bond (DR) UCITS ETF - LU1829219127
PRESS RELEASE published on 01/11/2023 at 10:00, 2 years 10 months ago AMUNDI ETF – Important Information – Mergers on Amundi Funds – 27/1/2023
Published on 12/05/2025 at 02:35, 5 hours 8 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 43 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 38 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 43 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 43 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 13 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 52 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 18 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 28 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 43 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 58 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 59 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
